top of page

BackTable / Urology / Podcast / Episode #169

Prostate Cancer: Navigating Focal Therapy Options

with Dr. Matthew Cooperberg and Dr. Arvin George

In this episode, Dr. Matthew Cooperberg (UC San Francisco) and Dr. Arvin George (Johns Hopkins) join host Dr. Aditya Bagrodia in a conversation about guidelines and treatment algorithms for focal therapy in prostate cancer treatment.

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Prostate Cancer: Navigating Focal Therapy Options with Dr. Matthew Cooperberg and Dr. Arvin George on the BackTable Urology Podcast
Ep 169 Prostate Cancer: Navigating Focal Therapy Options with Dr. Matthew Cooperberg and Dr. Arvin George
00:00 / 01:04

BackTable, LLC (Producer). (2024, May 28). Ep. 169 – Prostate Cancer: Navigating Focal Therapy Options [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Aditya Bagrodia on the BackTable Urology Podcast

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Dr. Matthew Cooperberg on the BackTable Urology Podcast

Dr. Matthew Cooperberg is a professor at UCSF in San Francisco, California.

Dr. Arvin George on the BackTable Urology Podcast

Dr. Arvin George is an associate professor of urology at the University of Michigan in Ann Arbor.

Synopsis

First, the doctors discuss focal therapy in prostate cancer treatment from various perspectives, including the challenges of treating certain lesions, the comparison of different focal therapy modalities like high-intensity focused ultrasound (HIFU) and brachytherapy, cryotherapy and the importance of patient-specific factors in treatment decisions. They emphasize the need for clinical trials and registries to validate focal therapy outcomes, the potential expansion of indications for focal therapy, and the critical role of advanced imaging and genomic classifiers in patient selection and treatment planning. The discussion also touches on the potential of focal therapy to evolve as a standard care option alongside advancements in understanding the biology of prostate cancer and improving imaging and treatment technologies.

Timestamps

00:00 - Introduction
05:24 - Focal Therapy Definitions, Techniques, and Patient Selection
11:45 - Ideal Patients for Focal Therapy
25:30 - The Role of Genomic Classifiers in Treatment Decisions
30:56 - Addressing High-Risk Patient Concerns
37:51 - Advancements and Considerations in Focal Therapy Modalities
56:13 - The Future of Focal Therapy

Resources

Transcript Preview

[Dr. Matt Cooperberg]:
There's this old saying that in surgical oncology, biology is king, and all the surgeons, and here you can throw in radiation oncologists and focal therapists and everybody else are the princess trying to overthrow the king, often to no avail. I think ultimately, it comes down to understanding the cancer more and more at the biological level. I think that the role for focal therapy is clearly going to grow as we can identify those tumors that are actually confined to the prostate, and we can visualize them with imaging, increasingly with functional imaging, as our focal modalities get more and more guided by real-time feedback from imaging.

Clearly, it makes sense. You look at the history, everyone always draws the analogy to breast cancer and lumpectomy, taking over from mastectomy. Obviously, there's a lot of different considerations in prostate compared to breast but nonetheless, the idea of treating the tumor rather than the prostate makes a lot of sense for a certain band of cancers. As we're able to identify that band, figure out the ones that need treatment and yet need less than total treatment and pelvic treatment, as we can identify those and target them, of course, the role here will continue to grow.

The only way we're going to identify those tumors is to take this seriously, to as we've said at the beginning, put patients that are undergoing focal therapy in a registry, on a trial, collect the data, be honest about our outcomes, and constantly be striving to improve those outcomes with research and improvements in our treatments.

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Enhancing Care Coordination in Bladder Cancer Treatments with Brynn Moore and Meredith Donahue on the BackTable Urology Podcast
How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka on the BackTable Urology Podcast
Beyond PSA: The Science Driving Smarter Blood Tests with Dr. Jason Hafron on the BackTable Urology Podcast
Non-Muscle Invasive Bladder Cancer: Role of Medical Oncology with Dr. Tyler Stewart on the BackTable Urology Podcast
Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill on the BackTable Urology Podcast
Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast

Articles

Prostate Cancer Focal Therapy: Who is the Ideal Patient?

Prostate Cancer Focal Therapy: Who is the Ideal Patient?

Evolving Guidelines on Focal Therapy for Prostate Cancer

Evolving Guidelines on Focal Therapy for Prostate Cancer

Topics

Brachytherapy Podcasts
Foley Catheter Podcasts
High-Intensity Focused Ultrasound (HIFU) Podcasts
Prostate Cancer Podcasts
Urologic Oncology Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page